These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9814666)

  • 1. Many faces of lupus anticoagulants.
    Triplett DA
    Lupus; 1998; 7 Suppl 2():S18-22. PubMed ID: 9814666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and therapeutic aspects associated to phospholipid binding antibodies (lupus anticoagulant and anticardiolipin antibodies).
    Ordi-Ros J; Pérez-Pemán P; Monasterio J
    Haemostasis; 1994; 24(3):165-74. PubMed ID: 7988946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune thrombophilic syndromes.
    Greaves M
    Haematologica; 1999 Jun; 84 Suppl EHA-4():32-5. PubMed ID: 10907462
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-prothrombin antibodies and their relation with thrombosis and lupus anticoagulant.
    de Groot PG; Horbach DA; Simmelink MJ; van Oort E; Derksen RH
    Lupus; 1998; 7 Suppl 2():S32-6. PubMed ID: 9814669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
    Arnout J
    Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lupus anticoagulant antibodies: recognition of phospholipid-binding protein complexes.
    Rauch J
    Lupus; 1998; 7 Suppl 2():S29-31. PubMed ID: 9814668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta2-glycoprotein I: target antigen for 'antiphospholipid' antibodies. Immunological and molecular aspects.
    Sheng Y; Kandiah DA; Krilis SA
    Lupus; 1998; 7 Suppl 2():S5-9. PubMed ID: 9814663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiphospholipid antibodies.
    Triplett DA
    Clin Adv Hematol Oncol; 2003 Dec; 1(12):726-30. PubMed ID: 16258476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
    Viveros ME; Cabiedes J; Reyes E; Cabral AR
    Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiphospholipid antibodies in children without and in adults with and without thrombophilia.
    Siemens HJ; Gutsche S; Brückner S; Bucsky P; Katus HA
    Thromb Res; 2000 May; 98(4):241-7. PubMed ID: 10822070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of action of beta2-glycoprotein I-dependent lupus anticoagulants.
    Arnout J; Vermylen J
    Lupus; 1998; 7 Suppl 2():S23-8. PubMed ID: 9814667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiphospholipid syndrome: diagnostic aspects of lupus anticoagulants.
    Arnout J
    Thromb Haemost; 2001 Jul; 86(1):83-91. PubMed ID: 11487046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Autoimmune thrombophilia].
    Heegaard NH; Locht H
    Ugeskr Laeger; 2005 Aug; 167(32):2861-4. PubMed ID: 16109186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiprothrombin antibodies: detection and clinical significance in the antiphospholipid syndrome.
    Galli M; Barbui T
    Blood; 1999 Apr; 93(7):2149-57. PubMed ID: 10090921
    [No Abstract]   [Full Text] [Related]  

  • 16. Which antiphospholipid antibodies should be measured in the antiphospholipid syndrome?
    Galli M
    Haemostasis; 2000; 30 Suppl 2():57-62. PubMed ID: 11251342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antiphospholipid antibodies: clinical significance and biological diagnosis].
    Arnoux D; Boutière B; Sanmarco M
    Ann Biol Clin (Paris); 2000; 58(5):557-74. PubMed ID: 11022099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of autoantibody-mediated thrombosis.
    Roubey RA
    Lupus; 1998; 7 Suppl 2():S114-9. PubMed ID: 9814687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiphospholipid syndrome: state of the art with emphasis on laboratory evaluation.
    Greaves M
    Haemostasis; 2000; 30 Suppl 2():16-25. PubMed ID: 11251337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lupus anticoagulants versus antiphospholipid antibodies].
    Pereira MI
    Acta Med Port; 1998 Apr; 11(4):349-57. PubMed ID: 9644846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.